Maria Arena

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

Silvia Stacchiotti, Elena Palassini, Roberta Sanfilippo et al. · Annals of Oncology · 2011 · 160 citations · Full text

Inventory of Nanotechnology applications in the agricultural, feed and food sector

Ruud Peters, Puck Brandhoff, Stefan Weigel et al. · EFSA Supporting Publications · 2014 · 124 citations · Full text

Food Sector, Agricultural Technology, Food Nanotechnology +15

Soil Bacterial Diversity Screening Using Single 16S rRNA Gene V Regions Coupled with Multi-Million Read Generating Sequencing Technologies

Sotirios Vasileiadis, Edoardo Puglisi, Maria Arena et al. · PLoS ONE · 2012 · 110 citations · Full text

Bioinformatics, Biology, Microbial Diversity +15